IONIS PHARMACEUTICALS INC
IONS
63 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Jul 1 9:29 PM | KLEIN JOSEPH III | Proposed Sale | 11,518 | $79.04 | $910.4K | — | View → |
| Jun 26, 2026 | Jun 30 9:48 PM | Joseph BaroldiEVP, Chief Business Officer | Sale | 5,635 | $80.16 | $451.7K | 4,669(I) | View → |
| Jun 26, 2026 | Jun 30 9:48 PM | Patrick R. O'NeilEVP CLO & General Counsel | Sale | 3,069 | $80.00 | $245.5K | 61,470(D) | View → |
| Jun 26, 2026 | Jun 30 9:48 PM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Sale | 26,000 | $81.05 | $2.1M | 77,114(D) | View → |
| Jun 26, 2026 | Jun 26 11:09 PM | Brett P MoniaDirector, Chief Executive Officer | Sale | 50,000 | $80.59 | $4.0M | 245,571(D) | View → |
| Jun 25, 2026 | Jun 26 11:09 PM | Brett P MoniaDirector, Chief Executive Officer | Sale | 21,072 | $78.49 | $1.7M | 245,571(D) | View → |
| Jun 24, 2026 | Jun 26 11:09 PM | Brett P MoniaDirector, Chief Executive Officer | Sale | 14,565 | $78.41 | $1.1M | 245,571(D) | View → |
| Jun 25, 2026 | Jun 26 11:09 PM | Eric SwayzeEVP Research | Sale | 10,602 | $79.18 | $839.5K | 21,759(D) | View → |
| Jun 26, 2026 | Jun 26 9:48 PM | Baroldi Mariana | Proposed Sale | 5,635 | $80.16 | $451.7K | — | View → |
| Jun 26, 2026 | Jun 26 9:47 PM | O'NEIL PATRICK R. | Proposed Sale | 3,069 | $80.00 | $245.5K | — | View → |
| Jun 26, 2026 | Jun 26 9:43 PM | Schneider Eugene | Proposed Sale | 47,884 | $81.05 | $3.9M | — | View → |
| Jun 25, 2026 | Jun 25 10:53 PM | Swayze Eric | Proposed Sale | 10,602 | $79.16 | $839.3K | — | View → |
| Jun 12, 2026 | Jun 16 9:26 PM | Holly B. KordasiewiczEVP, Chief Development Officer | Sale | 60,846 | $73.41 | $4.5M | 22,458(D) | View → |
| Jun 15, 2026 | Jun 16 9:26 PM | BERTHELSEN SPENCER RDirector | Sale | 8,000 | $73.49 | $587.9K | 156,013(D) | View → |
| Jun 15, 2026 | Jun 15 2:17 PM | BERTHELSEN SPENCER R | Proposed Sale | 8,000 | $73.49 | $587.9K | — | View → |
| Jun 12, 2026 | Jun 12 8:29 PM | Kordasiewicz Holly B. | Proposed Sale | 60,846 | $73.41 | $4.5M | — | View → |
| Jun 1, 2026 | Jun 3 9:34 PM | BERTHELSEN SPENCER RDirector | Sale | 8,000 | $75.67 | $605.4K | 156,013(D) | View → |
| Jun 1, 2026 | Jun 1 2:47 PM | BERTHELSEN SPENCER R | Proposed Sale | 8,000 | $75.67 | $605.4K | — | View → |
| May 14, 2026 | May 15 10:15 PM | Brett P MoniaDirector, Chief Executive Officer | Sale | 3,220 | $78.68 | $253.3K | 242,662(D) | View → |
| May 13, 2026 | May 15 10:15 PM | Brett P MoniaDirector, Chief Executive Officer | Sale | 1,316 | $78.01 | $102.7K | 242,662(D) | View → |
Page 1 of 10
Next →
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Mar 9, 2026 | Mar 11 8:19 PM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 114,351 | $60.89 | 34,103(D) | View → |
| Mar 10, 2026 | Mar 11 8:18 PM | Kyle JenneEVP, Chf GL Pdt Str Ofcr | Option Exercise | 37,277 | $46.10 | 32,601(D) | View → |
| Mar 4, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 200 | $38.06 | 10,968(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph LoscalzoDirector | Option Exercise | 832 | $38.06 | 11,168(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Joseph Klein IIIDirector | Option Exercise | 16,000 | $42.88 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Allene M. DiazDirector | Option Exercise | 40,321 | $41.08 | 0(D) | View → |
| Mar 3, 2026 | Mar 5 11:14 PM | Shannon L. DeversEVP, Chief Human Resources Ofc | Option Exercise | 20,106 | $52.87 | 8,877(D) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Mar 4, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 439 | $56.78 | 3,866(I) | View → |
| Mar 3, 2026 | Mar 5 11:13 PM | Joseph BaroldiEVP, Chief Business Officer | Option Exercise | 1,699 | $56.78 | 4,104(I) | View → |
| Feb 2, 2026 | Feb 4 9:06 PM | BENNETT C FRANKEVP, Chief Scientific Officer | Option Exercise | 65,089 | $60.89 | 0(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Michael J. YangDirector | Option Exercise | 1,930 | — | 7,150(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Grant/Award | 35,700 | $0.00 | 611(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eric SwayzeEVP Research | Option Exercise | 21,477 | — | 386(I) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Option Exercise | 21,685 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:21 AM | Eugene SchneiderEVP, Chf Clinical Develop Ofcr | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Option Exercise | 21,473 | — | 39,251(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Patrick R. O'NeilEVP CLO & General Counsel | Grant/Award | 35,475 | $0.00 | 48,926(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Grant/Award | 156,585 | $0.00 | 205,719(D) | View → |
| Jan 15, 2026 | Jan 21 1:20 AM | Brett P MoniaDirector, Chief Executive Officer | Option Exercise | 89,145 | — | 163,014(D) | View → |